Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
人类
EPHA2 - EPH Receptor A2
Alias:
ECK
CTPA
ARCC2
CTPP1
CTRCT6
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
Basic Information
Sequence Homology
Related Diseases and Mutations
Transcripts & Proteins
Gene Expression
Interactions
Related Mouse Models
Related Drugs
References Literature
这个基因属于酪氨酸激酶家族的 Ephrin 受体亚家族。 Eph 和 Eph 相关受体已被证明在调节发育事件中起作用,特别是在神经系统中。 Eph 亚家族的受体通常有一个酪氨酸激酶域和一个富含半胱氨酸的区域以及两个纤维连接蛋白 III 重复序列。 Ephrin 受体根据其外显子域序列的相似性和与 Ephrin-A 和 Ephrin-B 配体的亲和力被分为两组。 该基因编码一种能与 Ephrin-A 配体结合的蛋白质。 该基因的突变是某些遗传性白内障障碍的原因。 [由 RefSeq 提供,2010 年 5 月]
Related ID:
NCBI:1969
ENSEMBL:ENSG00000142627
HGNC:3386
UNIPROT:P29317
OMIM:176946
Basic Information
NCBI
Transcripts
Exons
Length
MW (kDa)
Mutations
Related Diseases
Related Mouse Models
Reference
1969
6
17
31733 bp
108.27
267
7
10
44
EPHA2 Genetics information (-)
GRCh38
Sequence Homology
Related Diseases and Mutations
#
Disease
Anatomical Category
Score
Mutations
No data available
Transcripts & Proteins
Table View
Tile View
#
Transcript
Length(nt)
Exon Count
CDS(bp)
Protein
Length(aa)
No data available
* This data comes from NCBI.
Gene Expression
Tissue-specific RNA expression
Organ
Abundance
Alphabetical
Cell-specific RNA expression
Organ
Abundance
Alphabetical
Interactions
Reset
Acting
Regulation
Detail
Mechanism
Target
Residues
Reference
Score
No data available
Related Mouse Models
Type
Name
MGI
Strain of Origin
Publications
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
Link
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
Wechat
Mutation Direct
Sequence
Comparison
Al agent
Tutorials
Back to top